
Stent Graft Balloon Catheter Market Report 2026
Global Outlook – By Product (Stent Graft Balloon Catheters, Standard Balloon Catheters), By Application (Coronary Artery Disease (CAD) Treatment, Abdominal Aortic Aneurysm (AAA) Treatment, Peripheral Artery Disease (PAD) Treatment), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics) – Market Size, Trends, Strategies, and Forecast to 2035
Stent Graft Balloon Catheter Market Overview
• Stent Graft Balloon Catheter market size has reached to $2.77 billion in 2025 • Expected to grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 10% • Growth Driver: The Rising Prevalence Of Cardiovascular Diseases Driving The Growth Of The Market Due To Increasing Disease Burden And Need For Effective Vascular Restoration • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Stent Graft Balloon Catheter Market?
A stent graft balloon catheter is a specialized medical device used to deliver and deploy a stent graft within a blood vessel. It consists of a catheter with an inflatable balloon that helps precisely expand and position the stent graft at the target site, typically to reinforce weakened or diseased vessels. This device is commonly used in minimally invasive endovascular procedures to treat conditions such as aneurysms or vascular blockages. The main products of stent graft balloon catheter include stent graft balloon catheters and standard balloon catheters. Stent graft balloon catheters refer to specialized catheter-based devices used to deploy and expand stent grafts within blood vessels for treating vascular diseases and restoring proper blood flow. The different applications involved are coronary artery disease (CAD) treatment, abdominal aortic aneurysm (AAA) treatment, and peripheral artery disease (PAD) treatment, while the end-use includes hospitals, ambulatory surgical centers (ASCs), and specialty clinics.
What Is The Stent Graft Balloon Catheter Market Size and Share 2026?
The stent graft balloon catheter market size has grown strongly in recent years.It will grow from $2.77 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to rising prevalence of cardiovascular and vascular disorders, increasing geriatric population prone to aneurysms and arterial diseases, growing adoption of minimally invasive surgical techniques, expansion of hospital-based interventional cardiology procedures, technological advancements in catheter-based vascular treatment devices.What Is The Stent Graft Balloon Catheter Market Growth Forecast?
The stent graft balloon catheter market size is expected to see rapid growth in the next few years.It will grow to $4.47 billion by 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for advanced endovascular repair procedures, rising investment in next-generation vascular intervention technologies, growing integration of imaging and navigation systems in catheter procedures, expansion of outpatient vascular treatment centers, increasing development of flexible and high-performance balloon catheter materials.Major trends in the forecast period include increasing adoption of minimally invasive endovascular procedures, rising demand for low profile balloon catheter systems, growing preference for high pressure stent graft balloon catheters in complex vascular procedures, expansion of drug coated balloon catheter applications, increasing utilization of precision-guided vascular intervention devices.Global Stent Graft Balloon Catheter Market Segmentation
1) By Product: Stent Graft Balloon Catheters, Standard Balloon Catheters 2) By Application: Coronary Artery Disease (CAD) Treatment, Abdominal Aortic Aneurysm (AAA) Treatment, Peripheral Artery Disease (PAD) Treatment 3) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics Subsegments: 1) By Stent Graft Balloon Catheters: Compliant Balloon Stent Graft Catheters, Semi Compliant Balloon Stent Graft Catheters, Non Compliant Balloon Stent Graft Catheters, Low Profile Stent Graft Balloon Catheters, High Pressure Stent Graft Balloon Catheters, Large Diameter Stent Graft Balloon Catheters, Over The Wire Stent Graft Balloon Catheters, Rapid Exchange Stent Graft Balloon Catheters 2) By Standard Balloon Catheters: Compliant Standard Balloon Catheters, Semi Compliant Standard Balloon Catheters, Non Compliant Standard Balloon Catheters, Low Profile Standard Balloon Catheters, High Pressure Standard Balloon Catheters, Over The Wire Standard Balloon Catheters, Rapid Exchange Standard Balloon Catheters, Drug Coated Standard Balloon CathetersWhat Are The Drivers Of The Stent Graft Balloon Catheter Market?
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the stent graft balloon catheter industry going forward.Cardiovascular diseases refer to a group of disorders that affect the heart and blood vessels, including conditions such as coronary artery disease, peripheral artery disease, and aortic aneurysms that restrict or block normal blood flow.The increasing prevalence of cardiovascular diseases is primarily due to unhealthy dietary habits, which gradually disrupt normal cardiovascular function and lead to a higher burden of heart-related conditions in the population.A stent graft balloon catheters are used in cardiovascular diseases by enabling precise placement and expansion of stent grafts to open narrowed or weakened blood vessels, thereby restoring proper blood flow and supporting vessel integrity.For instance, in March 2025, according to the Joint Strategic Needs Assessment, a UK-based community health center, the number of deaths caused by cardiovascular disease (CVD) was 185 in 2023, compared to 178 recorded in 2022.Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the stent graft balloon catheter industry. The growing geriatric population is expected to propel the growth of the stent graft balloon catheter industry going forward.The geriatric population refers to the group of individuals typically aged 65 years and older who are considered elderly and may experience age-related physical, physiological, and social changes.The growing geriatric population is primarily due to increasing life expectancy, resulting from advancements in healthcare and improved disease management, allowing more people to reach older age.A stent graft balloon catheter helps the geriatric population by enabling precise deployment and expansion of stent grafts to treat age-related vascular conditions such as aneurysms and arterial blockages, improving blood flow and reducing the risk of life-threatening complications.For instance, in February 2025, according to the World Health Organization, a Switzerland‑based intergovernmental organization, the global population of people aged 60 years and older is rapidly increasing due to longer life expectancy and declining birth rates, with older adults projected to outnumber younger cohorts in many regions by 2030.Therefore, the growing geriatric population is driving the growth of the stent graft balloon catheter industry. The increasing healthcare expenditure is expected to propel the growth of the stent graft balloon catheter industry going forward.Healthcare expenditure refers to the total amount of financial resources allocated toward health services, including medical treatments, diagnostic procedures, medications, and preventive care.Healthcare expenditure is rising due to population aging because older populations have higher rates of chronic diseases, require more frequent medical care, and often need long-term treatments, driving overall healthcare costs upward.Increasing healthcare expenditure enables greater investment in advanced medical technologies and minimally invasive vascular procedures, driving the adoption and utilization of stent graft balloon catheters for effective treatment of complex cardiovascular and vascular diseases.For instance, in January 2026, according to the Centers for Medicare & Medicaid Services, a US-based government agency, in 2024, national health expenditure (NHE) increased by 7.2% to $5.3 trillion, averaging $15,474 per person and representing 18.0% of GDP.Therefore, increasing healthcare expenditure is driving the growth of the stent graft balloon catheter industry.Key Players In The Global Stent Graft Balloon Catheter Market
Major companies operating in the stent graft balloon catheter market are Abbott Laboratories, Boston Scientific Corporation, Shandong Weigao Group Medical Polymer Company Limited, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., Nordson Corporation, Cook Medical LLC, Lepu Medical Technology Co Ltd., MicroPort Scientific Corporation, Biomerics LLC, Freudenberg Group, Teleflex Medical OEM, Putnam Plastics Corporation, W. L. Gore & Associates Inc., Alvimedica Medikal Ürünler Sanayi ve Ticaret A. Ş., Natec Medical Ltd., Bentley InnoMed GmbH, Cardionovum GmbH, AndraTec GmbHRegional Insights
North America was the largest region in the stent graft balloon catheter market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Stent Graft Balloon Catheter Market?
The stent graft balloon catheter market consists of sales of non-compliant balloon catheters, occlusion balloon catheters, aortic stent graft molding balloons, drug-coated balloon catheters, and semi-compliant balloon catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.What is the Market Assessment and Strategic Outlook for the Stent Graft Balloon Catheter Industry?
The stent graft balloon catheter market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stent graft balloon catheter industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.What is the Market Assessment and Strategic Outlook for the Stent Graft Balloon Catheter Market Report 2026?
The stent graft balloon catheter market research report is one of a series of new reports from The Business Research Company that provides stent graft balloon catheter market statistics, including stent graft balloon catheter industry global market size, regional shares, competitors with a stent graft balloon catheter market share, detailed stent graft balloon catheter market segments, market trends and opportunities, and any further data you may need to thrive in the stent graft balloon catheter industry. This stent graft balloon catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.Stent Graft Balloon Catheter Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.05 billion |
| Revenue Forecast In 2035 | $4.47 billion |
| Growth Rate | CAGR of 10.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Abbott Laboratories, Boston Scientific Corporation, Shandong Weigao Group Medical Polymer Company Limited, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., Nordson Corporation, Cook Medical LLC, Lepu Medical Technology Co Ltd., MicroPort Scientific Corporation, Biomerics LLC, Freudenberg Group, Teleflex Medical OEM, Putnam Plastics Corporation, W. L. Gore & Associates Inc., Alvimedica Medikal Ürünler Sanayi ve Ticaret A. Ş., Natec Medical Ltd., Bentley InnoMed GmbH, Cardionovum GmbH, AndraTec GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
